Gossamer Bio Inc (GOSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -91,661 | -49,165 | -229,378 | -173,614 | -114,251 |
| Depreciation Amortization | -55 | -39 | 4,187 | 3,938 | 2,932 |
| Accounts payable and accrued liabilities | 716 | 1,223 | -1,813 | -2,098 | 1,204 |
| Other Working Capital | -14,415 | -11,204 | -1,738 | 1,250 | -10,653 |
| Other Operating Activity | 14,175 | 6,196 | 41,710 | 31,222 | 18,463 |
| Operating Cash Flow | $-91,240 | $-52,989 | $-187,032 | $-139,302 | $-102,305 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 21,688 | 8,737 | -560 | -9,141 | 13,411 |
| PPE Investments | N/A | N/A | -410 | -308 | -277 |
| Other Investing Activity | -30 | -15 | -65 | -50 | -35 |
| Investing Cash Flow | $21,658 | $8,722 | $-1,035 | $-9,499 | $13,099 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,807 | -2,903 | -5,806 | -2,903 | 0 |
| Common Stock Issued | 367 | 367 | 122,896 | 122,866 | 742 |
| Financing Cash Flow | $-5,440 | $-2,536 | $117,090 | $119,963 | $742 |
| Exchange Rate Effect | 53 | 72 | -517 | -1,152 | -687 |
| Beginning Cash Position | 111,973 | 111,973 | 183,467 | 183,467 | 183,467 |
| End Cash Position | 37,004 | 65,242 | 111,973 | 153,477 | 94,316 |
| Net Cash Flow | $-74,969 | $-46,731 | $-71,494 | $-29,990 | $-89,151 |
| Free Cash Flow | |||||
| Operating Cash Flow | -91,240 | -52,989 | -187,032 | -139,302 | -102,305 |
| Capital Expenditure | N/A | N/A | -410 | -308 | -277 |
| Free Cash Flow | -91,240 | -52,989 | -187,442 | -139,610 | -102,582 |